[1]
|
陈万青, 孙可欣, 郑荣寿, 张思维, 曾红梅, 邹小农, 赫捷. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2018, 27(1): 1-14.
|
[2]
|
Zerbini, A., Pilli, M., Fagnoni, F., et al. (2008) Increased Immunostimulatory Activity Conferred to Antigen-Presenting Cells by Exposure to Antigen Extract from Hepatocellular Carcinoma after Radiofre-quency Thermal Ablation. Journal of Immunotherapy, 31, 271-282. https://doi.org/10.1097/CJI.0b013e318160ff1c
|
[3]
|
闫景彬, 闫秀梅, 陈斌, 等. 超声引导射频消融术对肝癌患者免疫功能的影响[J]. 浙江中西医结合杂志, 2015, 22(3): 228-232.
|
[4]
|
张汉洋, 庄志彬, 林春冬, 等. 经皮射频消融术与腹腔镜肝切除术治疗原发性小肝癌的疗效及预后比较[J]. 中国普通外科杂志, 2019, 28(1): 24-30.
|
[5]
|
徐治军, 许戈良, 马金良, 等. 超声引导下经皮射频消融与腹腔镜肝切除术治疗原发性小肝癌的对比研究[J]. 中国普通外科杂志, 2017, 26(1): 18-24.
|
[6]
|
Helling, T.S. (2000) Realistic Expectations for Cryoablation of Liver Tu-mors. Journal of Hepato-Biliary-Pancreatic Sciences, 7, 510-515. https://doi.org/10.1007/s005340070023
|
[7]
|
史东宏, 许健, 曹建民. 肝脏肿瘤冷冻消融治疗的进展[J]. 中国介入影像与治疗学, 2007(4): 321-324.
|
[8]
|
方驰华, 陈小伍, 钟洪才. 术中氩氦刀治疗中晚期肝癌适应证的选择及其相关并发症[J]. 中华肝胆外科杂志, 2006, 12(6): 381-383. https://doi.org/10.3760/cma.j.issn.1007-8118.2006.06.008
|
[9]
|
Si, T., Guo, Z. and Hao, X. (2008) Im-munologic Response to Primary Cryoablation of High-Risk Prostate Cancer. Cryobiology, 57, 66-71. https://doi.org/10.1016/j.cryobiol.2008.06.003
|
[10]
|
Li, J., Chen, X., Yang, H., et al. (2011) Tumour Cryoablation Combined with Palliative Bypass Surgery in the Treatment of Unresectable Pancreatic Cancer: A Retrospective Study of 142 Patients. Postgraduate Medical Journal, 87, 89-95. https://doi.org/10.1136/pgmj.2010.098350
|
[11]
|
Si, T.G., Guo, Z., Wang, H.T., et al. (2009) Cryoablation for Prostate Cancer Induces Tumor-Specific Immune Response. Nation-al Journal of Andrology, 15, 350-353.
|
[12]
|
Ebara, M., Okabe, S., Kita, K., et al. (2005) Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma: Therapeutic Efficacy Based on 20-Year Observation. Journal of Hepatology, 43, 458-464.
https://doi.org/10.1016/j.jhep.2005.03.033
|
[13]
|
Giorgio, A., Tarantino, L., de Stefano, G., et al. (2000) Ultra-sound-Guided Percutaneous Ethanolinjection under General Anesthesia for the Treatment of Hepatocellular Carcinoma on Cirrhosis: Long-Term Results in 268 Patients. European Journal of Ultrasound, 12, 145-154. https://doi.org/10.1016/S0929-8266(00)00113-0
|
[14]
|
Tominaga, Y., Tanaka, Y., Sato, K., et al. (1997) Histo-pathology, Pathophysiology, and Indications for Surgical Treatment of Renal Hyperparathyroidism. Seminars in Surgical Oncology, 13, 78-86.
https://doi.org/10.1002/(SICI)1098-2388(199703/04)13:2<78::AID-SSU3>3.0.CO;2-Z
|
[15]
|
黄进, 李文伦, 王会东, 等. 超声引导高温蒸馏水加干扰素瘤内注射治疗肝癌的研究[J]. 中国超声医学杂志, 2006, 22(11): 855-858.
|
[16]
|
任志刚, 陈新华, 周琳, 郑树森. 纳秒脉冲肿瘤消融的研究进展[J]. 中国生物医学工程学报, 2014, 33(5): 620-624.
|
[17]
|
塔来提•吐尔干, 张瑞青, 陈新华, 温浩, 邵英梅, 吐尔干艾力•阿吉. 肝癌纳秒脉冲治疗后外周血Th_(17)细胞及相关细胞因子变化实验观察[J]. 中华肿瘤防治杂志, 2021, 28(1): 27.
|
[18]
|
程敏怡, 王坤. 乳腺癌新辅助内分泌治疗最新研究进展[J]. 循证医学, 2016, 16(2): 119-124.
|
[19]
|
Hoff, P.M., Valero, V., Buzdar, A.U., et al. (2000) Combined Modality Treatment of Locally Advanced Breast Carcinoma in Elderly Patients or Patients with Severe Comorbid Conditions Using Tamoxifen as the Primary Therapy. Cancer, 88, 2054-2060. https://doi.org/10.1002/(SICI)1097-0142(20000501)88:9<2054::AID-CNCR11>3.0.CO;2-J
|
[20]
|
帅琰洁. 乳腺癌新辅助化疗后病理完全缓解及分子分型的变化与预后的关系[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2018.
|
[21]
|
Francica, G., Petrolati, A., Di Stasio, E., et al. (2012) Effectiveness, Safety, and Local Progression after Per-cutaneous Laser Ablation for Hepatocellular Carcinoma Nodules Up to 4 cm Are Notaffected by Tumor Location. Amer-ican Journal of Roentgenology, 199, 1393-1401. https://doi.org/10.2214/AJR.11.7850
|
[22]
|
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版) [J]. 中华肝脏病杂志, 2022, 30(4): 367-388.
|